Published in Am J Pathol on October 01, 1994
Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat Immunol (2001) 9.23
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol (1999) 4.12
B cells regulate murine gammaherpesvirus 68 latency. J Virol (1999) 2.79
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol (1999) 2.56
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol (1996) 2.19
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Characterization of gammaherpesvirus 68 gene 50 transcription. J Virol (2000) 1.84
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol (1999) 1.53
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol (2005) 1.46
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J Virol (2008) 1.36
Gammaherpesvirus lytic gene expression as characterized by DNA array. J Virol (2002) 1.33
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe (2009) 1.30
A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog (2005) 1.30
An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol (2004) 1.28
Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol (2006) 1.25
Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol (2004) 1.24
Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J Virol (2000) 1.24
Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J Virol (2007) 1.18
Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J (2009) 1.11
Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos Trans R Soc Lond B Biol Sci (2000) 1.09
Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog (2006) 1.08
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J Virol (2006) 1.04
Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio (2014) 1.04
Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections. J Virol (2008) 1.03
Murine models of B-cell lymphomas: promising tools for designing cancer therapies. Adv Hematol (2012) 1.01
Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50. J Virol (2010) 1.01
Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency. J Virol (2004) 0.98
COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J Virol (2003) 0.98
Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection. J Virol (2004) 0.98
Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J Virol (2001) 0.98
Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res (2009) 0.98
A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection. J Virol (2009) 0.97
Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J Virol (2005) 0.96
Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. Clin Exp Immunol (2014) 0.94
Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes. J Virol (2009) 0.93
The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection. PLoS Pathog (2011) 0.91
Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog (2006) 0.91
Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome. J Biomed Biotechnol (2010) 0.91
Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog (2012) 0.89
Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model? J Exp Med (2002) 0.87
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency. J Virol (2005) 0.87
Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology (2001) 0.86
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J Exp Med (2001) 0.84
Pervasive transcription of a herpesvirus genome generates functionally important RNAs. MBio (2014) 0.83
Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol Res (2010) 0.82
Establishment of murine gammaherpesvirus latency in B cells is not a stochastic event. PLoS Pathog (2014) 0.82
Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines. J Virol (2006) 0.81
Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection. PLoS One (2013) 0.80
Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus. J Virol (2004) 0.79
Vaccination against a hit-and-run viral cancer. J Gen Virol (2010) 0.79
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host. Front Microbiol (2016) 0.78
Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines. J Virol (2001) 0.78
Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1. J Virol (2014) 0.77
The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J Virol (2004) 0.77
Molecular detection of murine herpesvirus 68 in ticks feeding on free-living reptiles. Microb Ecol (2011) 0.77
A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo. PLoS Pathog (2014) 0.77
Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo. J Virol (2013) 0.75
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med (1989) 6.66
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1990) 3.41
Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol (1990) 3.33
Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1973) 3.14
Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol (1980) 3.09
Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci U S A (1986) 2.84
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med (1993) 2.56
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res (1981) 2.39
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med (1991) 2.20
Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation (1990) 2.13
In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol (1989) 1.60
Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology (1993) 1.51
Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest (1990) 1.49
Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol (1990) 1.31
Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins. J Virol (1989) 1.11
Lymphoproliferative disease in organ transplant recipients. Springer Semin Immunopathol (1991) 1.01
Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol (1990) 0.93
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol (1984) 2.48
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol (1996) 2.37
Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol (2000) 2.35
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol (1996) 2.19
Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol (1980) 1.96
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J Immunol (1981) 1.66
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol (1996) 1.64
T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene (1992) 1.64
The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol (1987) 1.64
Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol (1997) 1.54
Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology (1993) 1.51
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68. J Gen Virol (1997) 1.49
Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J Gen Virol (1980) 1.45
Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol (1983) 1.42
Role of antibody in primary and recurrent herpes simplex virus infection. J Virol (1985) 1.41
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110). J Virol (1994) 1.35
Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine (1999) 1.34
Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology (1999) 1.25
Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am J Pathol (2001) 1.23
Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J Gen Virol (1987) 1.23
Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol (1988) 1.18
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. J Gen Virol (1991) 1.15
Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis (1987) 1.14
The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol (1992) 1.13
Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis. J Virol (2001) 1.11
Semliki Forest virus strongly reduces mosquito host defence signaling. Insect Mol Biol (2008) 1.09
Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity. Immunology (1982) 1.08
Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch Virol (2000) 1.06
Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology (1981) 1.04
Murine gammaherpesvirus-68 infection of and persistence in the central nervous system. J Gen Virol (2000) 1.02
Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.02
Tolerance and suppression in virus diseases. Br Med Bull (1985) 1.02
Two groups of human herpesvirus 6 identified by sequence analyses of laboratory strains and variants from Hodgkin's lymphoma and bone marrow transplant patients. J Gen Virol (1993) 1.01
Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro. J Gen Virol (1999) 0.99
A solid-phase system (SPACE) for the detection and quantification of rotavirus in faeces. J Gen Virol (1979) 0.99
Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34. J Clin Pathol (1999) 0.98
Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J Virol (2001) 0.98
Immunological control of murine gammaherpesvirus infection is independent of perforin. J Gen Virol (1997) 0.97
Behavioural changes in the rat following infection with varicella-zoster virus. J Gen Virol (1999) 0.96
Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. J Gen Virol (2001) 0.96
Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression. Prog Neurobiol (2000) 0.96
Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology (1993) 0.96
Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte. J Gen Virol (1980) 0.95
Antioxidant status in asthma. Pediatr Pulmonol (1994) 0.95
Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology (1990) 0.94
2'-Deoxy-5-ethyl-beta-4'-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency. Antivir Chem Chemother (1999) 0.92
Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. J Gen Virol (1990) 0.90
Role of neutralizing antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice. Immunol Lett (1982) 0.89
In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol (1993) 0.88
Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology (1984) 0.88
T cell-macrophage interactions in the immune response to herpes simplex virus: the significance of interferon-gamma. J Gen Virol (1986) 0.87
A human leukaemic cell expressing hybrid membrane phenotypes. Nature (1977) 0.87
Survey of savanna chimpanzees (Pan troglodytes verus) in Southeastern Sénégal. Am J Primatol (2002) 0.87
Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. J Gen Virol (1989) 0.86
Lymphocyte recognition of picornaviruses. J Gen Virol (1995) 0.84
Chronic coronary periarteritis in two patients with chronic periaortitis. J Clin Pathol (1984) 0.84
Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. Oncogene (1993) 0.84
Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology (1992) 0.84
Separation of lymphocyte sub-populations using antibodies attached to staphylococcal protein A-coated surfaces. J Immunol Methods (1976) 0.83
Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. J Gen Virol (1993) 0.82
The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40. J Interferon Cytokine Res (1999) 0.82
Stress as a precipitating factor in subjects with recurrent herpes labialis. J Fam Pract (1985) 0.81
Sinus histiocytosis with massive lymphadenopathy: virological, immunological and morphological studies. Br J Haematol (1980) 0.81
Theiler's virus: an experimental model of virus-induced demyelination. Autoimmunity (1990) 0.81
Polymorphic radiation sensitivity of human natural killer activity: possible role of DNA strand breakage. Hum Immunol (1985) 0.81
Lymphocyte recognition elements on the VP1 protein of Theiler's virus. Immunology (1995) 0.81
Sinus histiocytosis with massive lymphadenopathy--properties of cultured histiocytes. Eur J Cancer (1973) 0.81
Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease. Immunology (1998) 0.80
Seminoma and intestitial-cell tumour of the testis. Br J Surg (1968) 0.79
Pathogenesis and immunobiology of herpes simplex virus in mouse and man. Cancer Invest (1985) 0.79
Reduced in vitro adherence of Staphylococcus species to feline corneocytes compared to canine and human corneocytes. Vet Dermatol (2008) 0.78
T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus. Virus Res (1984) 0.78
Clonal analysis of the T-cell response of mice to herpes simplex virus: correlation between lymphokine production in vitro and the induction of delayed-type hypersensitivity and antiviral activity in vivo. Viral Immunol (1987) 0.78
Experimental herpes simplex virus type 1 (HSV-1) infection of the spinal cord and dorsal root ganglia. Neuropathol Appl Neurobiol (1995) 0.78
"Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol (1994) 0.77
The PI capsid region of Theiler's virus controls replication in mouse glial cell cultures. Arch Virol (1997) 0.77
Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126. Peptides (1990) 0.77
The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J Virol (2004) 0.77
Expansion and activation of NK cell populations in a gammaherpesvirus infection. Scand J Immunol (2008) 0.76
Characterisation of the immune response in a neural xenograft rejection paradigm. J Neuroimmunol (1997) 0.75
Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice. Immunology (1997) 0.75
Breast lumps and lymphoma. Postgrad Med J (1985) 0.75
Cell-mediated immune responses in herpes simplex virus-infected mice. Prog Brain Res (1983) 0.75
Electron microscopic study on the role of delayed hypersensitivity & antibody producing cells in protection against herpes simplex virus in nude mice. Indian J Med Res (1987) 0.75
Theiler's murine encephalomyelitis virus 3D RNA polymerase: its expression in the CNS and the specific immune response generated in persistently infected mice. J Gen Virol (1995) 0.75
Virus-cell interactions in the nervous system and the role of the immune response. Curr Opin Neurobiol (1993) 0.75
The neurobiology of alphaherpesvirus infections. Acta Vet Hung (1994) 0.75
Clonal analysis of T cell responses to herpes simplex virus: a HSV-specific, non cytolytic T cell clone displays specific helper activity for T cell response in vitro. Immunol Lett (1986) 0.75
Relative role of B and T lymphocytes in pathogenesis of a murine herpes virus. Indian J Exp Biol (1992) 0.75